Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The global burden of listeriosis: a systematic review and meta-analysis.
de Noordhout CM, Devleesschauwer B, Angulo FJ, Verbeke G, Haagsma J, Kirk M, Havelaar A, Speybroeck N. de Noordhout CM, et al. Among authors: verbeke g. Lancet Infect Dis. 2014 Nov;14(11):1073-1082. doi: 10.1016/S1473-3099(14)70870-9. Epub 2014 Sep 15. Lancet Infect Dis. 2014. PMID: 25241232 Free PMC article. Review.
Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European country.
Molenberghs G, Buyse M, Abrams S, Hens N, Beutels P, Faes C, Verbeke G, Van Damme P, Goossens H, Neyens T, Herzog S, Theeten H, Pepermans K, Abad AA, Van Keilegom I, Speybroeck N, Legrand C, De Buyser S, Hulstaert F. Molenberghs G, et al. Among authors: verbeke g. Contemp Clin Trials. 2020 Dec;99:106189. doi: 10.1016/j.cct.2020.106189. Epub 2020 Oct 22. Contemp Clin Trials. 2020. PMID: 33132155 Free PMC article.
Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK.
Conrad N, Verbeke G, Molenberghs G, Goetschalckx L, Callender T, Cambridge G, Mason JC, Rahimi K, McMurray JJV, Verbakel JY. Conrad N, et al. Among authors: verbeke g. Lancet. 2022 Sep 3;400(10354):733-743. doi: 10.1016/S0140-6736(22)01349-6. Epub 2022 Aug 27. Lancet. 2022. PMID: 36041475 Free article.
The analysis of multivariate longitudinal data: a review.
Verbeke G, Fieuws S, Molenberghs G, Davidian M. Verbeke G, et al. Stat Methods Med Res. 2014 Feb;23(1):42-59. doi: 10.1177/0962280212445834. Epub 2012 Apr 20. Stat Methods Med Res. 2014. PMID: 22523185 Free PMC article. Review.
The analysis of multivariate longitudinal data: A review.
Verbeke G, Fieuws S, Molenberghs G, Davidian M. Verbeke G, et al. Stat Methods Med Res. 2017 Feb;26(1):112. doi: 10.1177/0962280214539862. Stat Methods Med Res. 2017. PMID: 28054505 No abstract available.
Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial.
Gyselinck I, Liesenborghs L, Landeloos E, Belmans A, Verbeke G, Verhamme P, Vos R, Janssens W; DAWn-Azithro consortium. Gyselinck I, et al. Among authors: verbeke g. Trials. 2021 Feb 9;22(1):126. doi: 10.1186/s13063-021-05033-x. Trials. 2021. PMID: 33563325 Free PMC article.
Cancer mortality and age: relationship with dietary fat.
Kesteloot H, Sasaki S, Verbeke G, Joossens JV. Kesteloot H, et al. Among authors: verbeke g. Nutr Cancer. 1994;22(1):85-98. doi: 10.1080/01635589409514334. Nutr Cancer. 1994. PMID: 11304913
A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study.
Vanassche T, Engelen MM, Van Thillo Q, Wauters J, Gunst J, Wouters C, Vandenbriele C, Rex S, Liesenborghs L, Wilmer A, Meersseman P, Van den Berghe G, Dauwe D, Verbeke G, Thomeer M, Fivez T, Mesotten D, Ruttens D, Heytens L, Dapper I, Tuyls S, De Tavernier B, Verhamme P; DAWn consortium members. Vanassche T, et al. Among authors: verbeke g. Trials. 2020 Dec 9;21(1):1005. doi: 10.1186/s13063-020-04878-y. Trials. 2020. PMID: 33298149 Free PMC article. Clinical Trial.
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial.
Devos T, Geukens T, Schauwvlieghe A, Ariën KK, Barbezange C, Cleeren M, Compernolle V, Dauby N, Desmecht D, Grimaldi D, Lambrecht BN, Luyten A, Maes P, Moutschen M, Romano M, Seyler L, Nevessignsky MT, Vandenberghe K, van Griensven J, Verbeke G, Vlieghe E, Yombi JC, Liesenborghs L, Verhamme P, Meyfroidt G. Devos T, et al. Among authors: verbeke g. Trials. 2020 Nov 27;21(1):981. doi: 10.1186/s13063-020-04876-0. Trials. 2020. PMID: 33246499 Free PMC article. Clinical Trial.
174 results